<DOC>
	<DOC>NCT00568087</DOC>
	<brief_summary>The present study is designed to find out if N-acetylcysteine works in reducing alcohol drinking and craving.</brief_summary>
	<brief_title>N-acetylcysteine in Alcohol Dependence</brief_title>
	<detailed_description>The 2 groups (placebo and N-acetylcysteine) will be compared in a double-blind, placebo-controlled trial. The total study duration is 9 weeks which includes a 1-week screening period and an 8-week randomized study drug treatment period.</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>age 18 65 alcohol dependence by DSMIV heavy drinking at least 4 times in the past month able to provide informed consent current drug abuse or dependence by DSMIV criteria (except nicotine or cannabis) current psychotic disorders, bipolar disorders, or cognitive disorders current suicidal or homicidal ideation positive illicit drug screen (except cannabis) Clinical Institute Withdrawal Assessment for Alcohol, Revised &gt;15 initiation of individual therapy or counseling in the past 3 months changes in doses of psychiatric medications in the past 3 months clinically unstable cardiac, hepatic, renal, neurologic, or pulmonary disease current use of naltrexone, disulfiram or acamprosate pregnant or nursing women, or inadequate birth control methods in women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>N-acetylcysteine</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Treatment</keyword>
</DOC>